";s:4:"text";s:5189:" Onset of Action for Cyclophosphamide N/A Duration of Action for Cyclophosphamide N/A Half Life of Cyclophosphamide N/A Side Effects of Cyclophosphamide 1. … Exposure to cyclophosphamide during pregnancy may cause fetal malformations, miscarriage, fetal growth retardation, and toxic effects in the newborn. Present in the blood, it is practically inactive, although upon penetrating cancerous cells This means that the alkylating action of this drug is specifically directed toward cancerous cells. Pulmonary fibrosis 13. The reduced toxicity has allowed the development of a high-dose regimen of cyclophosphamide to be used in combination with busulfan or with total body irradiation, for allogenic or autologous bone marrow transplantation.The initial CYP-450-catalysed metabolic step leads to the formation of 4-hydroxymetabolites, 4-hydroxycyclophosphamide (OHCP) or 4-hydroxyifosfamide (OHIF), that equilibrate with their ring-opened aldo tautomers, aldocyclophosphamide (AldoCP) or aldoifosfamide (AldoIF) (Ten years later, Martino’s group using a 300 MHz spectrometer analysed urine samples of nine patients treated with IF at a dose of 3 g/mCyclophosphamide was synthesized by Arnold and coworkersThe distinctive chemical structure of this drug gives it selective antineoplastic activity. Cyclophosphamide was approved for medical use in the United States in 1959.Because of its potential side effects, cyclophosphamide is used for early phases of treatment and later substituted by other medications, such as High-dose intravenous cyclophosphamide can cause the Cyclophosphamide has been found to significantly increase the risk of This risk may be dependent on dose and other factors, including the condition, other agents or treatment modalities (including Oral cyclophosphamide is rapidly absorbed and then converted by mixed-function It is specifically in the oxazaphosphorine group of medications.Cyclophosphamide metabolites are primarily excreted in the urine unchanged, and drug dosing should be appropriately adjusted in the setting of renal dysfunction.The main effect of cyclophosphamide is due to its metabolite phosphoramide mustard. Hepatotoxicity 8. Drugs that are designed to prevent proliferation for purposes of controlling the malignancy also affect normal lymphocytes undergoing proliferation as a result of an immune stimulus. Anemia 12. Cyclophosphamide is soluble in wate…
There is a robust literature describing both the extent and the mechanism of this low-dose CTX enhancement. Cyclophosphamide is teratogenic and embryo-fetal toxic … Hemorrhagic cystitis 9. Chest radiographs generally reveal a bibasilar interstitial and alveolar pattern and computed tomography (CT) scanning reveals ground-glass opacifications. Phosphoramide mustard, one of the principal toxic metabolites of cyclophosphamide, was synthesized and reported by Friedman and Seligman in 1954The abbreviation CP is common, although abbreviating drug names is not Because of its impact on the immune system, it is used in animal studies. A unique radiographic feature of cyclophosphamide-induced pulmonary toxicity is bilateral pleural thickening of the mid- and upper lung zones (Cyclophosphamide itself is not a pulmonary toxin; however, it is metabolized in the liver to the toxic metabolites 4-hydroxycyclophosphamide, acrolein, and phosphoramide mustard. Increases in TGF-β and procollagen mRNA appear to be a mechanism for collagen deposition and fibrosis. Cyclophosphamide is a cytotoxic (cytostatic), cell cycle nonspecific, antiproliferative agent which is used in such diverse medical problems as neoplasia, tissue transplantation and inflammatory diseases.In a mouse model of sarcoma using photodynamic therapy (PDT) and cyclophosphamide, PDT alone led to tumor regression but no permanent survival (In agreement with this, low doses of cyclophosphamide selectively decreased Tregs in patients with various tumor types and improved T cell and NK cell function, while higher doses depleted all T cells and decreased T cell- and NK cell-mediated immunity (The reliance of cyclophosphamide upon metabolism in order to generate the desired cytotoxic species In contrast to the aforementioned nitrogen mustard-based agents, cyclophosphamide shows reduced reports of nonhematopoetic toxicity. Rodents are injected intraperitoneally with either a single dose of 150 mg/kg or two doses (150 and 100 mg/kg) spread over two days.Medication used as chemotherapy and to suppress the immune systemInChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)